Brinton Pharmaceuticals
PrivateLast Round
Debt
Sep 16, 2020
Est. Valuation
$25M
Total Funding Raised
$13.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Brinton Pharmaceuticals operates in Healthcare & Life Sciences and is based in Pune. Its latest recorded funding round was a Debt round in September 2020.
Brinton Pharmaceuticals is a pharmaceutical company that provides clinical and cosmetic dermatology formulations intended to cure skin and hair problems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brinton Pharmaceuticals Comparables
Compare Brinton Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eris Lifesciences Limited | 78% | |
| Glenmark Pharmaceuticals Limited | 77% | |
| Torrent Pharmaceuticals Limited | 74% |
For institutional investors. Book with your work email.
Brinton Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 16, 2020 | ||||
| Series B | Jun 17, 2019 | ||||
| Series A | May 4, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brinton Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tata Capital Healthcare Fund | Series A |
| Marigold Capital | Series A |
| BlackSoil | Debt |
| India Alternatives Investment Advisors | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 154, 21% of headcount.
- Jul 28, 2026
Monthly visitors increased 161% MoM, reaching 48.2K.
For institutional investors. Book with your work email.
Brinton Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brinton Pharmaceuticals's valuation, stock price, and market status.
Is Brinton Pharmaceuticals a public or private company?
Brinton Pharmaceuticals is a private company.
What is the current stock price of Brinton Pharmaceuticals?
Brinton Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Brinton Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brinton Pharmaceuticals worth (valuation)?
Brinton Pharmaceuticals's valuation is estimated at $25.0M based on funding round data.
Can I buy Brinton Pharmaceuticals stock?
Brinton Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brinton Pharmaceuticals's last funding round?
Brinton Pharmaceuticals's most recent funding round was Debt on September 16, 2020.
Who are the main investors in Brinton Pharmaceuticals?
Key investors in Brinton Pharmaceuticals include Tata Capital Healthcare Fund, BlackSoil, India Alternatives Investment Advisors.
Will Brinton Pharmaceuticals IPO soon?
No public IPO plans have been announced for Brinton Pharmaceuticals.
How can I track Brinton Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Brinton Pharmaceuticals's shares on secondary markets.